Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2023 (2)
  • 2022 (5)
  • 2021 (3)
  • 2020 (1)
  • 2019 (1)

Subject

  • Pharmaceuticals/Pharmacists/Physicians (6)
  • Prescription Drugs (6)
  • Drug Trafficking (3)
  • Synthetic drugs (3)
  • Arrests/Convictions - Major (2)
  • Diversion Division (2)
  • Outreach/Drug Prevention (2)
  • Guilty Plea (1)
  • Guns/Weapons (1)
  • Major Law Enforcement Operation (1)
  • OCDETF/Task Force (1)
  • Overdose (1)

Drug Name

  • Cocaine (145)
  • Fentanyl (131)
  • Methamphetamine (130)
  • Heroin (50)
  • Marijuana (Cannabis) (19)
  • Oxycodone (19)
  • Hydromorphone (6)
  • Ecstasy/MDMA (5)
  • Amphetamines (4)
  • Benzodiazepines (2)
  • Methadone (2)
  • Morphine (1)
  • Steroids (1)
  • Opioids (9)
  • Synthetic Opioids (6)

Field Division

  • Washington, DC (112)
  • Atlanta (21)
  • Sede (9)
  • Dallas (8)
  • Detroit (8)
  • New York (8)
  • Seattle (8)
  • New England (7)
  • San Francisco (7)
  • Chicago (5)
  • Houston (5)
  • St. Louis (5)
  • New Orleans (4)
  • Rocky Mountain (3)
  • New Jersey (2)
  • Los Angeles (1)
  • Louisville (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
  • Miami (14)
Clear All Results
PRESS RELEASE

Doctor Convicted at Trial for Unlawfully Dispensing Controlled Substances

Enero 19, 2024
MIAMI – On January 12, a Miami federal court jury convicted a doctor of conspiracy to unlawfully dispense and distribute controlled substances, and six counts of unlawfully dispensing controlled substances. The conviction followed a seven-day trial before U.S. District Judge James I. Cohn. Under federal law, a physician is authorized...
Enero 19, 2024
PRESS RELEASE

South Florida Man Pleads Guilty to Participating in a Conspiracy to Distribute Protonitazene from China

Enero 12, 2024
MIAMI – A south Florida defendant pled guilty to participating in a conspiracy to possess with intent to distribute a synthetic opioid, protonitazene. Will Catis, Sr. (Catis), 42, of Deerfield Beach, pled guilty before U.S. District Judge Raag Singhal. According to the agreed upon factual proffer, on April 12, 2022...
Enero 12, 2024
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
PRESS RELEASE

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics

Enero 11, 2023
MIAMI – Dr. Ronald Lubetsky was sentenced this week to five (5) years in prison by U.S. District Judge Donald M. Middlebrooks for unlawfully dispensing narcotics—specifically oxycodone and morphine. Lubetsky was convicted at trial in November on seven counts of unlawfully dispensing narcotics. Trial evidence showed that law enforcement learned...
Enero 11, 2023
PRESS RELEASE

Federal Court Issues Temporary Restraining Order Prohibiting Tampa-Area Clinic from Distributing Opioids and Other Prescription Drugs

Octubre 18, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area clinic, its operators and a doctor from administering, dispensing or distributing any controlled substances, including issuing prescriptions for opioids, the Department of Justice announced. In a complaint filed on Oct. 11 and unsealed Oct. 14, the United...
Octubre 18, 2022
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

Agosto 19, 2022
MIAMI – On Sunday, August 21, the Drug Enforcement Administration (DEA) will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations...
Agosto 19, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

Julio 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
Julio 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

Julio 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
Julio 27, 2022
PRESS RELEASE

DEA Miami Field Division Warns of Alarming Increase in Suspected Fentanyl-Related Overdoses in Florida

Julio 15, 2022
MIAMI - Today, the Drug Enforcement Administration (DEA) Miami Field Division has issued a Public Safety Alert to warn Florida communities of the increase of mass-overdose events across the state suspected to be related to drug supplies laced with a synthetic opioid. While law enforcement agencies continue to investigate these...
Julio 15, 2022
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

Noviembre 01, 2021
MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
Noviembre 01, 2021
Showing 1 - 10 of 14 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster